United States Alopecia Market Size, Share, and COVID-19 Impact Analysis, By Disease Type (Alopecia Areata, Cicatricial Alopecia, Traction Alopecia, Androgenetic Alopecia, and Others), By Treatment (Pharmaceuticals, Oral, and Devices), and United States Alopecia Market Insights, Industry Trend, Forecasts to 2035

United States Alopecia Market Insights Forecasts to 2035

• The United States Alopecia Market Size Was Estimated at USD 3190.5 Million in 2024
• The Market Size is Expected to Grow at a CAGR of Around 5.83% from 2025 to 2035
• The United States Alopecia Market Size is Expected to Reach USD 5949.8 Million by 2035

According to a research report published by Spherical Insights & Consulting, the United States Alopecia Market is anticipated to reach USD 5949.8 million by 2035, growing at a CAGR of 5.83% from 2025 to 2035. The USA alopecia market is driven by various factors, including rising awareness regarding alopecia treatment, rising hair loss prevalence, rising demand for effective treatment, and advancements in pharmaceutical formulations.

Market Overview

Alopecia refers to the loss of partial or complete hair from body areas where hair normally occurs, usually the scalp. It includes various types such as alopecia areata, cicatricial, traction, and androgenetic alopecia. The United States alopecia market is a market for products and services used to manage or treat alopecia. Treatment includes pharmaceutical drugs, oral supplements, topical therapies and medical devices. The USA has the highest ageing population, which leads to a higher prevalence of alopecia, which further creates the demand for effective treatments for alopecia, which is one of the key driving factors for this market. Increased work-related stress, poor nutrition and changing lifestyle contributed to the hair loss conditions, which further boosts the market for alopecia. The growing demand for personalized medicines is a key trend in this market. The rising popularity of herbal and natural remedies presents an opportunity for product development by using natural ingredients.

Report Coverage

This research report categorizes the market for the United States alopecia market based on various segments and regions, and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United States alopecia market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the USA alopecia market.

Driving Factors

The United States alopecia market is witnessing steady growth owing to several factors. The USA alopecia rate is comparatively high in males, afflicted by middle age. Stress, diet, age, and environment are all speeding up hair loss, which further fuels demand for treatment. The advancement in technology of drugs such as targeted drugs (e.g., JAK inhibitors, Baricitinib) and the technology of less invasive surgeries, such as FUE hair transplants, are improving the effectiveness of treatments. Moreover, the increased application of PRP and low-level laser therapy is also propelling the growth of the market. Additionally, people are becoming aware of the importance of appearance, and personal grooming plays a crucial role in the expansion of the market.

Restraining Factors

One of the notable restraints is the high cost of treatment, which is unaffordable for price-sensitive consumers. Additionally, many people depend upon National Health Insurance, which usually does not cover new medications like JAK inhibitors. Thus, patients without full coverage pay very high out-of-pocket expenses for drugs, procedures, and specialist visits, which further limit the market expansion.

Market Segmentation

The United States Alopecia Market share is classified into disease type and distribution channel.

• The alopecia areata segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United States alopecia market is segmented by disease type into alopecia areata, cicatricial alopecia, traction alopecia, androgenetic alopecia, and others. Among these, the alopecia areata segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This segmental growth is attributed to the increasing prevalence of diseases. Additionally, people are becoming aware of the disease.  

• The pharmaceuticals segment held the dominant share in 2024 and is expected to grow at a substantial CAGR during the forecast period.

The United States alopecia market is segmented by distribution channel into pharmaceuticals, oral, and devices. Among these, the pharmaceuticals segment held the dominant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. This segmental growth is attributed to its affordability of pharmaceutical products and high usage of prescription & OTC drugs. Additionally, product innovation and R&D play a crucial role in segmental growth.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States alopecia market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Johnson & Johnson
• Merck & Co., Inc.
• Cipla Ltd.
• Sun Pharmaceutical Industries Ltd.
• Dr Reddy's Laboratories Ltd.
• AbbVie Inc.
• Pfizer Inc.
• Eli Lilly and Company
• Hims & Hers Health, Inc.
• Aclaris Therapeutics, Inc.
• Concert Pharmaceuticals
• Viatris Inc. (Mylan N.V.)
• Apira Science, Inc.
• Theradome Inc.
• Follica, Inc.
• Histogen Inc.
• Cellmid Limited
• Other

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the USA, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United States Alopecia Market based on the below-mentioned segments:

United States Alopecia Market, By Disease Type

• Alopecia Areata
• Cicatricial
• Traction
• Androgenetic Alopecia

United States Alopecia Market, By Treatment

• Pharmaceuticals
• Oral
• Devices